Related Experiment Videos
Immunostimulatory mouse granuloma protein.
Summary
Researchers purified a novel mouse granuloma protein that fully protects against Listeria monocytogenes infection. This protein also demonstrates cytostatic effects against Lewis carcinoma cells, indicating potential immunomodulatory roles.
Area of Science:
- Immunology
- Biochemistry
- Cell Biology
Background:
- Subcutaneous talc-induced granuloma extracts in mice confer protection against Listeria monocytogenes.
- The specific active factor responsible for this protection remained uncharacterized.
Purpose of the Study:
- To purify and characterize the protective factor from mouse granuloma extracts.
- To assess the biological activity and potential therapeutic applications of the purified factor.
Main Methods:
- Purification using ammonium sulfate fractionation, preparative electrophoresis, gel filtration chromatography, isoelectric focusing, and preparative polyacrylamide gel electrophoresis.
- Homogeneity assessment via NaDodSO4/polyacrylamide gel electrophoresis, revealing a single band with Mr 55,000.
- Characterization of migration with alpha 1-globulins and isoelectric point determination (pI 5 +/- 0.1).
Main Results:
- A homogeneous protein, termed "mouse granuloma protein," was isolated.
- The protein's biological activity was sensitive to Pronase but not trypsin.
- Intravenous injection of 5 micrograms of mouse granuloma protein conferred complete protection against lethal Listeria monocytogenes.
- Incubation of mouse peritoneal cells with 10 nM mouse granuloma protein induced cytostatic activity against Lewis carcinoma cells.
Conclusions:
- Mouse granuloma protein is a key mediator of protection against Listeria monocytogenes.
- The purified protein exhibits immunomodulatory properties, including anti-cancer cell activity.
- This protein represents a potential therapeutic agent for infectious diseases and cancer immunotherapy.